Abstract
Proper embryonic development and normal tissue homeostasis require a series of molecular processes, regulating cell growth, differentiation and apoptosis. Perturbation in any of these processes invariably contributes to the development of cancer. In particular, defects in apoptosis are seen in virtually all types of human cancers. The Notch pathway plays an important role in cell fate determination in both embryonic development and organ homeostasis. Not surprisingly, Notch also plays a role in cancer when it is dysregulated. In this chapter, we will explore how Notch signaling interacts with key pathways that regulate apoptosis in cancer. Particularly, we will focus on the relationship between Notch and proteins responsible for activation of the caspase pathway. Notch regulates apoptosis through extensive networks, involving cell cycle, growth and survival pathways. Thus, we will also examine how apoptosis is modulated by the crosstalk between Notch and other signaling pathways such as p53, NF-κB and PI3K-Akt pathways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239–257.
Danial Nika N, Korsmeyer Stanley J. Cell death: critical control points. Cell 2004; 116:205–219.
Bredesen Dale E, Rao Rammohan V, Mehlen Patrick. Cell death in the nervous system. Nature 2006; 443:796–802.
Chang Mi-Kyung, Binder Christoph J, Miller Yury I et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 2004; 200:1359–1370.
Cory S, Strasser A, Jacks T et al. Enhanced cell survival and tumorigenesis Cold Spring Harb Symp. Quant Biol 1994; 59:365–375.
Morgan TH. The Theory of the Gene. The American Naturalist 1917; 51:513.
Wharton KA, Johansen KM, Xu T et al. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 1985; 43:567–581.
Shellenbarger DL, Mohler JD. Temperature-sensitive periods and autonomy of pleiotropic effects of l(1) Nts1, a conditional notch lethal in Drosophila. Dev Biol 1978; 62:432–446.
Roy Monideepa, Pear Warren S, Aster Jon C. The multifaceted role of Notch in cancer. Curr Opin Genet Dev 2007; 17:52–59.
Curry Christine L, Reed Laura L, Golde Todd E et al. Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi’s sarcoma tumor cells. Oncogene 2005; 24:6333–6344.
Das Indranil, Craig Colleen, Funahashi Yasuhiro et al. Notch oncoproteins depend on gamma-secretase/ presenilin activity for processing and function. J Biol Chem 2004; 279:30771–30780.
Duechler M, Shehata M, Schwarzmeier JD et al. Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2. Leukemia 2005; 19:260–267.
Haruki Nobuhiro, Kawaguchi Keiko S, Eichenberger Shannon et al. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res 2005; 65:3555–3561.
Konishi Jun, Kawaguchi Keiko S, Vo Huan et al. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res 2007; 67:8051–8057.
Osipo C, Patel P, Rizzo P et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene 2008; 27:5019–5032.
Pannequin Julie, Bonnans Caroline, Delaunay Nathalie et al. The wnt target jagged-1 mediates the activation of notch signaling by progastrin in human colorectal cancer cells. Cancer Res 2009; 69:6065–6073.
Vousden Karen H, Lane David P. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8:275–283.
Hollstein M, Sidransky D, Vogelstein B et al. p53 mutations in human cancers. Science 1991; 253:49–53.
Sanchez-Cespedes M, Reed AL, Buta M et al. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in nonsmall cell lung cancer. Oncogene 1999; 18:5843–5849.
Higashiyama M, Doi O, Kodama K et al. MDM2 gene amplification and expression in nonsmall-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation. Br J Cancer 1997; 75:1302–1308.
Ladanyi M, Cha C, Lewis R et al. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 1993; 53:16–18.
Beverly Levi J, Felsher Dean W, Capobianco Anthony J. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. Cancer Res 2005; 65:7159–7168.
Kim SB, Chae GW, Lee J et al. Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation Cell Death Differ. 2007; 14:982–991.
Boggs Kristy, Henderson Brystol, Reisman David. RBP-Jkappa binds to and represses transcription of the p53 tumor suppressor gene. Cell Biol Int 2009; 33:318–324.
Gulino Alberto, Di Marcotullio Lucia, Screpanti Isabella. The multiple functions of Numb Exp. Cell Res 2010; 316:900–906.
Westhoff Britta, Colaluca Ivan N, D’Ario Giovanni et al. Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci USA 2009; 106:22293–22298.
Pece Salvatore, Serresi Michela, Santolini Elisa et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 2004; 167:215–221.
Colaluca Ivan N, Tosoni Daniela, Nuciforo Paolo et al. NUMB controls p53 tumour suppressor activity. Nature 2008; 451:76–80.
Wang Chunmei, Qi Runzi, Li Nan et al. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. J Biol Chem 2009; 284:16183–16190.
Yang Xudong, Klein Rüdiger, Tian Xiaolin et al. Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev Biol 2004; 269:81–94.
Lefort Karine, Mandinova Anna, Ostano Paola et al. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev 2007; 21:562–577.
Alimirah Fatouma, Panchanathan Ravichandran, Davis Francesca J et al. Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch1: implications for cancer cell fate determination after genotoxic stress. Neoplasia 2007; 9:427–434.
Wei Chia-Lin, Wu Qiang, Vega Vinsensius B et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006; 124:207–219.
Bassères DS, Baldwin AS. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25:6817–6830.
White DW, Roy A, Gilmore TD. The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells. Oncogene 1995; 10:857–868.
Beg AA, Sha WC, Bronson RT et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995; 376:167–170.
Oswald F, Liptay S, Adler G et al. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol 1998; 18:2077–2088.
Cheng P, Zlobin A, Volgina V et al. Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol 2001; 167:4458–4467.
Oakley Fiona, Mann Jelena, Ruddell Richard G et al. Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator. Notch1 J Biol Chem 2003; 278:24359–24370.
Bash J, Zong WX, Banga S et al. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO J 1999; 18:2803–2811.
Moran Stewart T, Cariappa Annaiah, Liu Haoyuan et al. Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. J Immunol 2007; 179:195–200.
Guan E, Wang J, Laborda J et al. T-cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T-cells. J Exp Med 1996; 183:2025–2032.
Wang J, Shelly L, Miele L et al. Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain. J Immunol 2001; 167:289–295.
Shin Hyun Mu, Minter Lisa M, Cho Ok Hyun et al. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 2006; 25:129–138.
Vilimas Tomas, Mascarenhas Joaquina, Palomero Teresa et al. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med 2007; 13:70–77.
Fernández-Majada V, Aguilera C, Villanueva A et al. Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci USA 2007; 104:276–281.
Paez Juan, Sellers William R. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 2003; 115:145–167.
Keniry M, Parsons R. The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 2008; 27:5477–5485.
Rangarajan A, Syal R, Selvarajah S et al. Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology 2001; 286:23–30.
Konishi J, Yi F, Chen X et al. Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim. Oncogene 2010; 29:589–596.
Stylianou Spyros, Clarke Rob B, Brennan Keith. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006; 66:1517–1525.
Meurette Olivier, Stylianou Spyros, Rock Rebecca et al. Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res 2009; 69:5015–5022.
Bedogni Barbara, Warneke James A, Nickoloff Brian J et al. Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 2008; 118:3660–3670.
Palomero Teresa, Sulis Maria Luisa, Cortina Maria et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13:1203–1210.
Perumalsamy Lakshmi R, Nagala Manjula, Sarin Apurva. Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival. Proc Natl Acad Sci USA 2010; 107:6882–6887.
Eliasz S, Liang S, Chen Y et al. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene 2010; 29:2488–2498.
Williams O, Norton T, Halligey M et al. The action of Bax and bcl-2 on T-cell selection. J Exp Med 1998; 188:1125–1133.
Hamnér S, Skoglösa Y, Lindholm D. Differential expression of bcl-w and bcl-x messenger RNA in the developing and adult rat nervous system. Neuroscience 1999; 91:673–684.
Bouillet Philippe, Strasser Andreas. BH3-only proteins—evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 2002; 115:1567–1574.
Morrow David, Sweeney Catherine, Birney Yvonne A et al. Cyclic strain inhibits Notch receptor signaling in vascular smooth muscle cells in vitro. Circ Res 2005; 96:567–575.
Wang Zhiwei, Zhang Yuxiang, Li Yiwei et al. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006; 5:483–493.
Sade Hadassah, Krishna Sudhir, Sarin Apurva. The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T-cells. J Biol Chem 2004; 279:2937–2944.
Nefedova Yulia, Sullivan Daniel M, Bolick Sophia C et al. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 2008; 111:2220–2229.
Qin Jian-Zhong, Stennett Lawrence, Bacon Patricia et al p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Mol Cancer Ther 2004; 3:895–902.
Wilson Nicholas S, Dixit Vishva, Ashkenazi Avi. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 2009; 10:348–355.
Quillard Thibaut, Devalliere Julie, Chatelais Mathias et al. Notch2 signaling sensitizes endothelial cells to apoptosis by negatively regulating the key protective molecule survivin. PLoS One 2009; 4:e8244.
Bushell Martin, Stoneley Mark, Kong Yi Wen et al. Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. Mol Cell 2006; 23:401–412.
Wang Wenli, Prince Chengyu Z, Mou Yongshan et al. Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. Resistance to Fas ligand-induced apoptosis. J Biol Chem 2002; 277:21723–21729.
Bheeshmachar Geetha, Purushotaman Divya, Sade Hadassah et al. Evidence for a role for notch signaling in the cytokine-dependent survival of activated T-cells. J Immunol 2006; 177:5041–5050.
O’Riordan Mary XD, Bauler Laura D, Scott Fiona L et al. Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation. Dev Cell 2008; 15:497–508.
Rosati Emanuela, Sabatini Rita, Rampino Giuliana et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 2009; 113:856–865.
Liu Wen-Hsien, Hsiao Huey-Wen, Tsou Wen-I et al. Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. EMBO J 2007; 26:1660–1669.
Jemal Ahmedin, Siegel Rebecca, Ward Elizabeth et al. Cancer statistics, 2009 CA. Cancer J Clin 2009; 59:225–249.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Dang, T.P. (2012). Notch, Apoptosis and Cancer. In: Reichrath, J., Reichrath, S. (eds) Notch Signaling in Embryology and Cancer. Advances in Experimental Medicine and Biology, vol 727. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0899-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0899-4_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0898-7
Online ISBN: 978-1-4614-0899-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)